Related Experiment Video
Updated: Aug 9, 2026

12:18
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Introduction to (pre)screening methods
1Huntingdon Research Centre, Huntingdon, Cambridgeshire, England.
Reproductive Toxicology (Elmsford, N.Y.)
|January 1, 1993
Summary
In vitro methods are not full replacements for animal testing in regulatory settings but offer value in identifying mechanisms of action and prioritizing specific chemical series in industries.
Area of Science:
- Toxicology
- Biomedical Research
- Chemical Safety Assessment
Background:
- Current regulatory testing relies heavily on animal models.
- There is a growing need for alternative testing strategies to reduce animal use.
- In vitro methods present potential but have limitations in broad application.
Purpose of the Study:
- To evaluate the efficacy and limitations of in vitro methods in regulatory testing.
- To determine the appropriate applications of in vitro techniques in chemical safety assessment.
- To explore the role of in vitro studies in integrated testing strategies.
Main Methods:
- The study presents a critical review of in vitro method applicability.
- It discusses the use of in vitro data for mechanism of action identification.
- The text considers the value of in vitro methods for screening and prioritization.
Main Results:
- In vitro methods are insufficient as complete replacements for animal testing in regulatory contexts.
- These methods are valuable for elucidating mechanisms of action as supporting studies.
- Their utility is limited for broad screening of diverse chemicals but can aid in prioritizing specific homologous series.
Conclusions:
- In vitro methods can supplement, but not replace, animal testing for regulatory purposes.
- Strategic application in integrated approaches, particularly in chemical and drug industries, can optimize testing and reduce late-stage failures.
- Further evaluation is needed to fully integrate in vitro data into safety assessment workflows.
Related Concept Videos
Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Sample Preparation for Analysis: Overview
Sample preparation is an essential step in the analytical process. It involves preparing a sample so that it can be analyzed accurately. The goal is to extract the analyte, the substance you want to measure, from the sample while removing any components that may interfere with the analysis. Sample preparation techniques vary depending on the physical state of the sample.
Bulk or large solid samples are typically reduced in size using grinding, crushing, or milling techniques to increase the...
Bulk or large solid samples are typically reduced in size using grinding, crushing, or milling techniques to increase the...
Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

